Pharmaceutical

Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (NASDAQ:BPTS), (Euronext Growth Paris:ALBPS), ("Biophytis" or…

9 months ago

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services…

9 months ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023

WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on…

9 months ago

Model N to be Acquired by Vista Equity Partners For $1.25 Billion

Model N Stockholders to Receive $30.00 Per Share in CashSAN MATEO, Calif.--(BUSINESS WIRE)--Model N (NYSE: MODN), a leader in revenue…

9 months ago

Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq’s Bid Price Requirement

Top line results forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrheaSAN FRANCISCO,…

9 months ago

DEA Faces Marijuana Legal Scrutiny: Hindering MMJ BioPharma Cultivation Marijuana Supply For Clinical Trials

Exposing the Secret: Federal Marijuana Production Remains NonexistentThe DEA Games Continue To Delay Legitimate Marijuana Clinical Trials and ResearchWASHINGTON, DC…

9 months ago

1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary

VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused…

9 months ago

Bristol Myers Squibb Releases 2023 ESG Report Demonstrating Progress and Setting New Long-Term Goals

Company builds on its strengths to advance patient access, product innovation, culture and inclusion and diversityNORTHAMPTON, MA / ACCESSWIRE /…

9 months ago

GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference

LA JOLLA, CA, April 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a…

9 months ago

Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today…

9 months ago